The global nanocapsules market is projected to reach USD 4 billion by 2025 growing at a CAGR of 7.9% during the forecast period (from 2014 to 2025). Nanocapsules supply bio-active molecules via targeted delivery and thus minimize adverse health effects. These vesicular systems are applied extensively in industries, such as food, healthcare, agriculture, and cosmetics. Widening application scope of these products holds good promise for the commercialization & development of improved solutions & therapies.
High prevalence of chronic ailments has spurred the demand for novel & efficient systems of drug delivery that can supply the required drug at the action site on time. Continuous R&D programs in the nanotechnology field can benefit this market in the long run. It may further lead to numerous growth opportunities across various industries. Industry growth is essentially credited to surging investments by various market players in commercialization and research activities.
The global market is categorized as per applications, therapies, and regions. On the basis of applications, the segments are food & nutraceuticals, healthcare, agricultural production, cosmetics, and others. Healthcare is considered a key application segment in the overall industry. The food science technology & nutrition segment is expected to grow rapidly throughout the forecast period. Popularity of nanotechnology in this segment offers huge growth potential due to its applications in food processing. Furthermore, cosmetics may register a healthy CAGR in the years to come. Effective delivery of active ingredients by nanocapsules in various skin care applications is a chief factor that fuels this segment.
In-depth research report on global nanocapsules market - http://www.grandviewresearch.com/industry-analysis/global-nanocapsules-market
Based on therapies, the market is classified into oncology, endocrinology, pain management, and others. Nanocapsules in oncology are designed to deliver anti-cancer agents to the exact tumor site. Significant advancements in the areas of endocrinology & pain management with regard to nanocapsule drug delivery are in the pipeline and are expected to facilitate product commercialization in the near future. Endocrinology is expected to be the second largest end user in the years to come. Acromegaly & diabetes are two of its core areas that are currently witnessing extensive research to fulfill unmet medical requirements.
On the basis of regions, the global industry is divided into the Middle East & Africa (MEA), Europe, Latin America, North America, and Asia-Pacific (APAC). Europe & North America collectively accounted for more than half the overall market in terms of revenue. The regions are propelled by high investments in R&D activities for the development of new & highly efficient therapies involving nanocapsules. It is anticipated that APAC will grow considerably over the next few years due to widespread application of nanocapsules in life sciences. Being a highly developed country, Japan employs nanocapsules in a host of applications, such as genetic engineering, agrochemicals, cosmetics, and many others.
Major companies operating in the worldwide market are Camurus AB; Cerulean Pharma Inc.; CARLINA Technologies; NanoSphere Health Science LLC.; and BioDelivery Sciences International Inc. The global industry exhibits immense growth potential because of the presence of key & promising products in the pipeline mainly across the healthcare sector. Scientists at the Lomonosov Moscow State University recently developed new, unique, and effective nanocapsules for targeted drug delivery. These are considered by far the finest carriers for targeted drug deliveries. In addition, this synthesis is neither costly nor complex.